Technical Analysis for TVTX - Travere Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 7.18 | -4.14% | -0.31 |
TVTX closed down 4.14 percent on Monday, March 18, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
NR7-2 | Range Contraction | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
NR7 | Range Contraction | -4.14% | |
Gapped Up | Strength | -4.14% | |
Oversold Stochastic | Weakness | -4.14% | |
Fell Below 20 DMA | Bearish | -4.65% |
Alert | Time |
---|---|
Possible NR7 | about 8 hours ago |
60 Minute Opening Range Breakout | about 9 hours ago |
Lower Bollinger Band Support | about 10 hours ago |
60 Minute Opening Range Breakdown | about 12 hours ago |
Down 3% | about 12 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Medical Genetics Kidney Disease Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Medical Genetics Kidney Disease Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 23.175 |
52 Week Low | 5.25 |
Average Volume | 1,274,447 |
200-Day Moving Average | 10.79 |
50-Day Moving Average | 8.50 |
20-Day Moving Average | 7.99 |
10-Day Moving Average | 8.01 |
Average True Range | 0.51 |
RSI (14) | 38.65 |
ADX | 12.41 |
+DI | 18.61 |
-DI | 26.60 |
Chandelier Exit (Long, 3 ATRs) | 7.51 |
Chandelier Exit (Short, 3 ATRs) | 8.66 |
Upper Bollinger Bands | 8.77 |
Lower Bollinger Band | 7.21 |
Percent B (%b) | -0.02 |
BandWidth | 19.56 |
MACD Line | -0.22 |
MACD Signal Line | -0.15 |
MACD Histogram | -0.0757 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 7.68 | ||||
Resistance 3 (R3) | 7.72 | 7.59 | 7.59 | ||
Resistance 2 (R2) | 7.59 | 7.47 | 7.57 | 7.56 | |
Resistance 1 (R1) | 7.39 | 7.39 | 7.33 | 7.35 | 7.54 |
Pivot Point | 7.26 | 7.26 | 7.23 | 7.24 | 7.26 |
Support 1 (S1) | 7.06 | 7.14 | 7.00 | 7.02 | 6.82 |
Support 2 (S2) | 6.93 | 7.06 | 6.91 | 6.80 | |
Support 3 (S3) | 6.73 | 6.93 | 6.77 | ||
Support 4 (S4) | 6.69 |